Clinical Trial Update: Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating doxycycline for treating bleeding in users of depot medroxyprogesterone acetate (DMPA) with uterine hemorrhage; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Hemorrhage

Drugs mentioned

• Depot Medroxyprogesterone Acetate (medroxyprogesterone acetate)
• Doxycycline (Doxycycline)

Snippet

Sponsor: Omar Mamdouh Shaaban | Conditions: Uterine Hemorrhage | Phase 3 | Status: COMPLETED